ABBOTT LABORATORIES (ABT) › Cost of RevenueABBOTT LABORATORIES (ABT) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2016: $9.09B2017: $12.41B2018: $12.71B2019: $13.23B2020: $15.00B2021: $18.54B2022: $19.14B2023: $17.98B2024: $18.71B2025: $19.32B$19.32B2016Cost of Revenue (USD)2025Fiscal YearCost of RevenueChange YoY2025$19.32B+3.3%2024$18.71B+4.1%2023$17.98B-6.1%2022$19.14B+3.3%2021$18.54B+23.6%2020$15.00B+13.4%2019$13.23B+4.1%2018$12.71B+2.4%2017$12.41B+36.5%2016$9.09B—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share